Geron Corp. (GERN)
1.51
-0.08
(-5.03%)
USD |
NASDAQ |
Sep 03, 16:00
1.51
0.00 (0.00%)
Pre-Market: 08:00
Geron Research and Development Expense (Annual) : 71.43M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 71.43M |
| December 31, 2024 | 103.74M |
| December 31, 2023 | 125.05M |
| December 31, 2022 | 95.52M |
| December 31, 2021 | 85.73M |
| December 31, 2020 | 51.49M |
| December 31, 2019 | 52.07M |
| December 31, 2018 | 13.43M |
| December 31, 2017 | 11.03M |
| December 31, 2016 | 18.05M |
| December 31, 2015 | 17.83M |
| December 31, 2014 | 20.71M |
| December 31, 2013 | 23.16M |
| December 31, 2012 | 51.37M |
| December 31, 2011 | 69.32M |
| Date | Value |
|---|---|
| December 31, 2010 | 61.69M |
| December 31, 2009 | 57.62M |
| December 31, 2008 | 51.65M |
| December 31, 2007 | 52.96M |
| December 31, 2006 | 39.81M |
| December 31, 2005 | 33.35M |
| December 31, 2004 | 26.28M |
| December 31, 2003 | 21.12M |
| December 31, 2002 | 26.59M |
| December 31, 2001 | 24.89M |
| December 31, 2000 | 23.55M |
| December 31, 1999 | 18.66M |
| December 31, 1998 | 15.62M |
| December 31, 1997 | 15.14M |
| December 31, 1996 | 14.26M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Precigen, Inc. | 40.06M |
| Editas Medicine, Inc. | 84.68M |
| Agenus, Inc. | 79.34M |
| Amgen, Inc. | 6.974B |
| Anika Therapeutics, Inc. | 25.77M |